New Zealand News
-
STA to distribute novel cancer drug in Australia, NZ
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 21 Aug, 2015
Singapore: Australian biopharmaceutical company, Specialised Therapeutics Australia (STA), has partnered with European...Read more
-
Sale of wound care devices spurs in Asia-Pacific: Frost & Sullivan analysis report
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 04 Sep, 2013
Singapore: Advanced wound care and modern wound closure products are gaining an edge over traditional wound dressings in...Read more
-
Lonza acquires New Zealand's agro development firm
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 05 Aug, 2015
Singapore: Swiss-based biosupplier giant Lonza has acquired New Zealand's Zelam - a developer and manufacturer for crop ...Read more
-
LanzaTech is the only bioscience firm on Forbes list
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 06 Feb, 2013
Singapore: Forbes magazine's top 100 list of America's 'most promising privately held companies' has ranked LanzaTech, a...Read more
-
BioSpectrum announces the hits and misses of 2013
New Zealand | Analysis | By BioSpectrum Bureau | 9 Comment | 02 Jan, 2014
Asia attracted a lot of interest from foreign multinational giants in the year 2013. This not only led to the increase i...Read more
-
BSA-CMR Survey: Asian CROs optimistic in a gloomy pharma market
New Zealand | Analysis | By BioSpectrum Bureau | 2 Comment | 18 Sep, 2013
Over the past four years, BioSpectrum Asia in association with CyberMedia Research (CMR) has been capturing the key br...Read more
-
NZ firm migrates to Aus to capitalize on MS drug
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 11 Sep, 2013
Singapore: New Zealand-based biopharmaceutical company Innate Immunotherapeutics is migrating to Australia in a move to ...Read more
-
Entering phase III involves much tech transfer: Dr Paul Tan
New Zealand | Influencers | By Piyusha Chatterjee | 0 Comment | 23 Jan, 2013
Living Cell Technologies, a cell implant company based out of Australia and New Zealand, appointed Dr Paul Tan as its ch...Read more
-
Aquaflow on the path to commercialize biofuels
New Zealand | Influencers | By Aishwarya Venkatesh | 2 Comment | 18 Jul, 2012
Aquaflow, a clean energy company, is working towards making refined next generation biofuels a commercial reality within...Read more
-
URMC launches new heart device trial in Asia
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 07 Aug, 2013
Singapore: Cardiologists at the University of Rochester Medical Center, US, are launching a new study in an effort to im...Read more
-
Biochips market to be worth $11.4 bn by 2018
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 09 Jul, 2013
Singapore: A recent report released by RnRMarketResearch.com has analyzed the Global Biochips Industry and forecasted th...Read more
-
Orion's e-health solution for Philippines hospital
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 03 Jul, 2014
Singapore: New Zealand-based health software company, Orion Health, has partnered with The Medical City (TMC), Philippin...Read more
-
NovaBay's new deal brings Avenova to patients in NZ
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 03 Sep, 2015
Singapore: NovaBay Pharmaceuticals announced collaboration with Ophthalmic Instrument Company to market NovaBay's breakt...Read more
-
Dr Jennifer Holmgren: I like to work on things people say can't be done
New Zealand | Influencers | By BioSpectrum Bureau | 0 Comment | 05 Mar, 2013
I believe in what Mr Thomas Edison has said, "Vision without execution is a hallucination". I was born in Colombia and m...Read more
-
Pacific Edge's Cxbladder achieves sales in the US
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 18 Oct, 2013
Singapore: New Zealand-based cancer diagnostic specialist Pacific Edge has completed the first commercial sales of Cxbla...Read more
-
Paul Hutchison: Ushering in a revolution in NZ's clinical trial sector
New Zealand | Influencers | By BioSpectrum Bureau | 2 Comment | 16 Nov, 2012
Dr Paul Hutchison is ushering in a new era in the history of New Zealand's healthcare sector. Dr Hutchison, a parliament...Read more
-
NZ can generate $300 mn from clinical trials by 2020
New Zealand | Analysis | By BioSpectrum Bureau | 2 Comment | 19 Nov, 2012
New Zealand is taking steps to improve the environment surrounding the country's clinical trial domain. With no accurate...Read more
-
LanzaTech chosen technology pioneer by World Economic Forum
New Zealand | News | By BioSpectrum Bureau | 0 Comment | 29 Aug, 2012
Singapore: LanzaTech, which provides novel and economic routes to fuels and high value chemicals from waste gas streams,...Read more
